An expansion of CD21–/low B cells has been described in SLE patients, where this cell population was identified as CD27+/–CD38low expressing IgM or IgG, and the frequency of these cells correlates with disease duration and SLEDAI score [8, 58, 59]. Here, CD27 is linked to systemic lupus erythematosus.